Marksans Pharma Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 | Sep-26 |
|---|---|---|---|---|---|---|---|---|
| 682 | 71 | 620 | 720 | 754 | 856 | 841 | 940 | |
| 28 | 2 | 6 | 22 | 20 | 35 | 25 | 18 | |
| 566 | 61 | 549 | 609 | 624 | 691 | 660 | 765 | |
| 189 | 19 | 193 | 228 | 274 | 265 | 221 | 231 | |
| 112 | 16 | 172 | 106 | 27 | 150 | 138 | 132 | |
| −3 | −2 | −102 | −25 | 15 | −24 | −16 | 27 | |
| 88 | 10 | 98 | 104 | 112 | 107 | 114 | 122 | |
| 3 | 0.34 | 6 | 6 | 6 | 6 | 7 | 7 | |
| 21 | 2 | 23 | 27 | 24 | 24 | 25 | 32 | |
| 156 | 16 | 160 | 164 | 165 | 163 | 170 | 213 | |
| 167 | 14 | 106 | 166 | 181 | 231 | 238 | 232 | |
| 146 | 12 | 83 | 139 | 157 | 206 | 214 | 200 | |
| 143 | 12 | 77 | 133 | 151 | 200 | 207 | 194 | |
| 38 | 3 | 18 | 34 | 37 | 51 | 47 | 50 | |
| 105 | 9 | 58 | 99 | 114 | 149 | 159 | 144 | |
| Financial ratios | ||||||||
| 24.44% | 20.07% | 17.06% | 23.05% | 23.98% | 26.94% | 28.36% | 24.72% | |
| 15.41% | 12.80% | 9.39% | 13.76% | 15.07% | 17.41% | 18.96% | 15.27% | |
| 2.31 | 2.00 | 1.29 | 2.17 | 2.50 | 3.27 | 3.47 | 3.12 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.